Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer
暂无分享,去创建一个
[1] E. Halm,et al. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. , 2010, American journal of respiratory and critical care medicine.
[2] Bengt Bergman,et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Marchetti,et al. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. , 2009, Lung cancer.
[4] J. Flickinger,et al. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer , 2009, Cancer.
[5] P. Goldstraw. Staging manual in thoracic oncology , 2009 .
[6] Alexander Rokitansky,et al. Thorax , 2009, Pediatric Surgery Digest.
[7] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[8] C. Divino,et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. , 2008, Journal of the American College of Surgeons.
[9] I. Park,et al. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. , 2008, The Annals of thoracic surgery.
[10] Igor Jurisica,et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] C. Klabunde,et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. , 2007, Annals of epidemiology.
[12] E. Halm,et al. Sex differences in lung cancer survival: do tumors behave differently in elderly women? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Jeremy J. W. Chen,et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.
[14] M. Roh,et al. Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma , 2007, Annals of Surgical Oncology.
[15] P. Pairolero,et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. , 2006, The Journal of thoracic and cardiovascular surgery.
[16] S. Mukherjee,et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.
[17] P. Catalano,et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] P. Johnstone,et al. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. , 2005, Chest.
[19] G. Vlastos,et al. Ratios of involved nodes in early breast cancer , 2004, Breast Cancer Research.
[20] W. E. Morgan,et al. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. , 2004, The Annals of thoracic surgery.
[21] O. Solak,et al. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[22] K. Yasumoto,et al. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. , 2004, Lung cancer.
[23] H. Herr. Superiority of ratio based lymph node staging for bladder cancer. , 2003, The Journal of urology.
[24] A. Marra,et al. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. , 2003, The Journal of thoracic and cardiovascular surgery.
[25] L. Voltolini,et al. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival? , 2003, The Journal of cardiovascular surgery.
[26] C. Belluco,et al. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience , 2003, Annals of Surgical Oncology.
[27] Gregory S. Cooper,et al. Studying Radiation Therapy Using SEER-Medicare-Linked Data , 2002, Medical care.
[28] Beth A Virnig,et al. Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.
[29] H. Wada,et al. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[30] A B de la Rivière,et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. , 2000, Chest.
[31] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[32] C. Mountain,et al. Regional lymph node classification for lung cancer staging. , 1997, Chest.
[33] R. Snijder,et al. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. , 1997, The Annals of thoracic surgery.
[34] Bonny R. Hart,et al. Prognostic significance of N1 disease in carcinoma of the lung. , 1983, The Journal of thoracic and cardiovascular surgery.
[35] C. Percy,et al. Accuracy of cancer death certificates and its effect on cancer mortality statistics. , 1981, American journal of public health.